Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines

Insulin degludec/insulin aspart (IDegAsp) is a fixed‐ratio co‐formulation of insulin degludec, which provides long‐lasting basal insulin coverage, and insulin aspart, which targets postprandial glycaemia. This review provides expert opinion on the practical clinical use of IDegAsp, including: dose t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Obes Metab
Main Authors: Mehta, Roopa, Chen, Roger, Hirose, Takahisa, John, Mathew, Kok, Adri, Lehmann, Roger, Unnikrishnan, Ambika Gopalakrishnan, Yavuz, Dilek Gogas, Fulcher, Gregory
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2020
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689716/
https://ncbi.nlm.nih.gov/pubmed/32618405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14128
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki